CRLF3
Cytokine receptor-like factor 3
Also known as: CREME9, CRLF3_HUMAN, CYTOR4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IUI8
- Gene
- CRLF3
- Ensembl
- ENSG00000176390
- Chromosome
- 17
- Canonical length
- 442 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a cytokine receptor-like factor that may negatively regulate cell cycle progression at the G0/G1 phase. Studies of the related rat protein suggest that it may regulate neuronal morphology and synaptic vesicle biogenesis. This gene is one of several genes located in the neurofibromatosis type I tumor suppressor region on the q arm of chromosome 17, a region that is subject to microdeletions, duplications, chromosomal breaks and rearrangements. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2 and 5. [provided by RefSeq, Aug 2012]
Canonical amino-acid sequenceUniProt
442 residues, UniProt reviewed canonical sequence.
>Q8IUI8|CRLF3
1 MRGAMELEPE LLLQEARENV EAAQSYRREL GHRLEGLREA RRQIKESASQ TRDVLKQHFN
61 DLKGTLGKLL DERLVTLLQE VDTIEQETIK PLDDCQKLIE HGVNTAEDLV REGEIAMLGG
121 VGEENEKLWS FTKKASHIQL DSLPEVPLLV DVPCLSAQLD DSILNIVKDH IFKHGTVASR
181 PPVQIEELIE KPGGIIVRWC KVDDDFTAQD YRLQFRKCTS NHFEDVYVGS ETEFIVLHID
241 PNVDYQFRVC ARGDGRQEWS PWSVPQIGHS TLVPHEWTAG FEGYSLSSRR NIALRNDSES
301 SGVLYSRAPT YFCGQTLTFR VETVGQPDRR DSIGVCAEKQ DGYDSLQRDQ AVCISTNGAV
361 FVNGKEMTNQ LPAVTSGSTV TFDIEAVTLG TTSNNEGGHF KLRVTISSNN REVVFDWLLD
421 QSCGSLYFGC SFFYPGWKVL VFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRLF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 33 nTPM
- thymus: 31 nTPM
- tonsil: 31 nTPM
- spleen: 22 nTPM
- appendix: 20 nTPM
- bone marrow: 19 nTPM
Single-cell type
- neutrophils: 350 nCPM
- cardiomyocytes: 274 nCPM
- neutrophil progenitors: 249 nCPM
- rod photoreceptor cells: 238 nCPM
- epicardial cells: 234 nCPM
- retinal bipolar cells: 225 nCPM
Immune cell
- eosinophil: 139 nTPM
- neutrophil: 117 nTPM
- naive CD4 T-cell: 100 nTPM
- total PBMC: 84 nTPM
- naive CD8 T-cell: 75 nTPM
- non-classical monocyte: 72 nTPM
Brain region
- cerebellum: 33 nTPM
- hippocampal formation: 21 nTPM
- cerebral cortex: 20 nTPM
- hypothalamus: 19 nTPM
- basal ganglia: 19 nTPM
- amygdala: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.12
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cell growth
- negative regulation of G1/S transition of mitotic cell cycle
- positive regulation of DNA-templated transcription
- positive regulation of receptor signaling pathway via JAK-STAT
- positive regulation of transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CRLF3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRLF3 as an antibody target. Whether an autoantibody or antibody against CRLF3 could matter depends on whether native CRLF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRLF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CRLF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...